OBJECTIVE—To review the effects of monotherapy with α-glucosidase inhibitors (AGIs) for
patients with type 2 diabetes, with respect to mortality, morbidity, glycemic control, insulin …

Aims Previous systematic reviews have found that drug‐related morbidity accounts for 4.3%
of preventable hospital admissions. None, however, has identified the drugs most commonly …

Background It is expected that GPs are increasingly confronted with a large group of patients
with symptoms persisting three weeks after initial symptoms of a mild (managed in the …

Background Alpha‐glucosidase inhibitors such as acarbose or miglitol, have the potential to
improve glycemic control in type 2 diabetes mellitus. The true value of these agents, …

PURPOSE Because recognition and management of patients with somatoform disorders
are difficult, we wanted to determine the specificity, sensitivity, and the test-retest reliability of …

OBJECTIVE: To study the course of medically unexplained symptoms (MUS), somatisation
disorder, and hypochondriasis, and related prognostic factors. Knowledge of prognostic …

Objective. To determine the effectiveness of whey hydrolysate formula in the treatment of
infantile colic in a primary care setting in the Netherlands. Study Design. Randomized, double-…

OBJECTIVES: The doctor–patient relationship has been linked to patient satisfaction, treatment
adherence, and treatment outcome. Many different instruments have been developed to …

Background Infantile colic is a common disorder, affecting around one in six families, and in
2001 was reported to cost the UK National Health Service in excess of£ 65 million per year (…

Background Alpha‐glucosidase inhibitors (AGIs) reduce blood glucose levels and may thus
prevent type 2 diabetes and cardiovascular disease in patients with impaired glucose …